TOBIRA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Tobira Therapeutics, Inc. (TBRA) Over the Proposed Sale of the Company to Allergan plc

Freitag, 23.09.2016 21:05 von

PR Newswire

NEW YORK, Sept. 23, 2016 /PRNewswire/ -- Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Tobira Therapeutics, Inc. ("Tobira" or the "Company") (NASDAQ: TBRA) for potential breaches of fiduciary duties in connection with the sale of the Company to Allergan plc for approximately $1.695 billion.

Faruqi & Faruqi, LLP. (PRNewsFoto/Faruqi & Faruqi, LLP)

The Company's stockholders will only receive $28.35 per share, plus one non-transferrable contingent value right per share to receive one or more payments in cash of up to $49.84 per share total, contingent upon the achievement of certain milestones, for each share of Company common stock they own.

Click here for more information: www.faruqilaw.com/TBRA. There is no cost or obligation to you.

The investigation focuses on whether Tobira's Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of Tobira's shareholders.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw. Faruqi & Faruqi, LLP is working together in this investigation with Juan E. Monteverde from Monteverde & Associates PC.

If you own common stock in Tobira and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/TBRA or contact Nadeem Faruqi, Esq. either via e-mail at nfaruqi@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330. You may also contact Juan E. Monteverde, Esq. either via email at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Faruqi & Faruqi, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Nadeem Faruqi, Esq. 
nfaruqi@faruqilaw.com 
Toll Free: (877) 247-4292
Phone: (212) 983-9330

Attorney Advertising. (C) 2016 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tobira-shareholder-notice-faruqi--faruqi-llp-announces-the-investigation-of-tobira-therapeutics-inc-tbra-over-the-proposed-sale-of-the-company-to-allergan-plc-300333350.html

SOURCE Faruqi & Faruqi, LLP